343 related articles for article (PubMed ID: 17659562)
41. Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR system.
Orbach DB; Wu C; Law M; Babb JS; Lee R; Padua A; Knopp EA
J Magn Reson Imaging; 2006 Jul; 24(1):16-24. PubMed ID: 16767701
[TBL] [Abstract][Full Text] [Related]
42. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.
Sajja BR; Narayana PA; Wolinsky JS; Ahn CW;
Mult Scler; 2008 Jan; 14(1):73-80. PubMed ID: 17881390
[TBL] [Abstract][Full Text] [Related]
43. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
[TBL] [Abstract][Full Text] [Related]
44. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ
J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577
[TBL] [Abstract][Full Text] [Related]
45. High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding.
Chen AP; Cunningham CH; Ozturk-Isik E; Xu D; Hurd RE; Kelley DA; Pauly JM; Kurhanewicz J; Nelson SJ; Vigneron DB
J Magn Reson Imaging; 2007 Jun; 25(6):1288-92. PubMed ID: 17520729
[TBL] [Abstract][Full Text] [Related]
46. 1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation.
Träber F; Block W; Lamerichs R; Gieseke J; Schild HH
J Magn Reson Imaging; 2004 May; 19(5):537-45. PubMed ID: 15112302
[TBL] [Abstract][Full Text] [Related]
47. Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.
Li Y; Srinivasan R; Ratiney H; Lu Y; Chang SM; Nelson SJ
J Magn Reson Imaging; 2008 Aug; 28(2):342-50. PubMed ID: 18666155
[TBL] [Abstract][Full Text] [Related]
48. Proton magnetic resonance spectroscopy in school-aged autistic children.
Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP
J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036
[TBL] [Abstract][Full Text] [Related]
49. Fast mapping of the T2 relaxation time of cerebral metabolites using proton echo-planar spectroscopic imaging (PEPSI).
Tsai SY; Posse S; Lin YR; Ko CW; Otazo R; Chung HW; Lin FH
Magn Reson Med; 2007 May; 57(5):859-65. PubMed ID: 17457864
[TBL] [Abstract][Full Text] [Related]
50. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
51. Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.
Guan JT; Xu XH; Geng YQ; Yu XJ; Wu RH
Brain Res; 2008 Aug; 1227():221-5. PubMed ID: 18602897
[TBL] [Abstract][Full Text] [Related]
52. Long-term normal-appearing brain tissue monitoring after irradiation using proton magnetic resonance spectroscopy in vivo: statistical analysis of a large group of patients.
Matulewicz Ł; Sokół M; Michnik A; Wydmański J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):825-32. PubMed ID: 16949766
[TBL] [Abstract][Full Text] [Related]
53. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
54. Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms.
Lin DD; Barker PB; Hatfield LA; Comi AM
J Magn Reson Imaging; 2006 Aug; 24(2):274-81. PubMed ID: 16786573
[TBL] [Abstract][Full Text] [Related]
55. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
[TBL] [Abstract][Full Text] [Related]
56. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
57. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM
Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293
[TBL] [Abstract][Full Text] [Related]
58. Diffusion-weighted imaging in patients with acute brain ischemia at 3 T: current possibilities and future perspectives comparing conventional echoplanar diffusion-weighted imaging and fast spin echo diffusion-weighted imaging sequences using BLADE (PROPELLER).
Fries P; Runge VM; Kirchin MA; Stemmer A; Naul LG; Wiliams KD; Reith W; Bücker A; Schneider G
Invest Radiol; 2009 Jun; 44(6):351-9. PubMed ID: 19363447
[TBL] [Abstract][Full Text] [Related]
59. Fast 1H spectroscopic imaging using a multi-element head-coil array.
Schäffter T; Börnert P; Leussler C; Carlsen IC; Leibfritz D
Magn Reson Med; 1998 Aug; 40(2):185-93. PubMed ID: 9702700
[TBL] [Abstract][Full Text] [Related]
60. [Shortening of the measurement time by 1H-MR turbo spectroscopic imaging of the brain].
Träber F; Block W; Lamerichs R; Keller E; Schild HH
Rofo; 1997 Mar; 166(3):221-9. PubMed ID: 9156593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
